Mastering Renal Cell Carcinoma Skeletal Metastasis Cases

Patient Presentation & History

A 68-year-old male, a retired accountant, presented to the emergency department with acute onset of severe left thigh pain following a minor fall from standing height. He described the pain as sharp, localized to the mid-distal femur, and completely debilitating, preventing any weight-bearing. He reported a several-month history of increasing, dull ache in the same region, exacerbated by activity and only partially relieved by NSAIDs, which he attributed to "old age." This discomfort had progressively worsened over the preceding 6 weeks, developing into a constant ache, occasionally disturbing his sleep. He denied direct trauma to the thigh prior to the fall, classifying the fall itself as a "twist and collapse."

His past medical history is significant for a left radical nephrectomy 4 years prior for T2N0M0 clear cell Renal Cell Carcinoma (RCC), followed by surveillance. He had no history of adjuvant therapy. Other comorbidities include well-controlled hypertension and hyperlipidemia. He is a former smoker (quit 15 years ago, 30 pack-year history) and an occasional social drinker. Family history is unremarkable for malignancies. His current medications include lisinopril and atorvastatin.

On initial assessment, the patient appeared in significant distress, rating his pain as 9/10 on the Visual Analog Scale. He reported generalized fatigue and a recent, unintentional weight loss of approximately 5 kg over the past 3 months. He denied any other new focal neurological deficits, constitutional symptoms such as fever or chills, or changes in bowel/bladder habits.

Clinical Examination

Upon initial examination, the patient was positioned supine on the stretcher, clearly unable to mobilize the left lower extremity.
* Inspection: Gross deformity of the left mid-distal thigh was evident, characterized by external rotation and shortening of the limb compared to the contralateral side. Significant soft tissue swelling was present around the mid-distal femoral region, extending proximally. The skin overlying the area appeared taut, with no open wounds, ecchymosis, or signs of inflammation.
* Palpation: There was exquisite tenderness to palpation circumferentially around the mid-distal femur. A palpable crepitus was elicited with minimal manipulation. The swelling was firm and diffuse. No overt pulsatile mass was appreciated on initial palpation, but the area was notably warmer than the surrounding skin. Peripheral pulses (femoral, popliteal, dorsalis pedis, posterior tibial) were all 2+ and symmetrical.
* Range of Motion (ROM): Active range of motion of the left hip and knee was impossible due to severe pain and mechanical blockage. Passive range of motion was severely restricted, particularly hip rotation and knee flexion/extension, with strong guarding. Any attempt at movement elicited significant pain and further crepitus.
* Neurological Assessment: Sensation to light touch was intact throughout the left lower extremity in all dermatomal distributions (L2-S1). Motor strength was difficult to fully assess due to pain, but active toe and ankle dorsiflexion/plantarflexion were present against gravity (3/5), though significantly limited by pain. Deep tendon reflexes (patellar, Achilles) were 2+ and symmetrical bilaterally. There were no signs of cauda equina syndrome.
* Vascular Assessment: Distal pulses were robust and symmetrical. Capillary refill was brisk in all digits of the left foot. No signs of acute limb ischemia were present.

A comprehensive general systems examination revealed no other focal neurological deficits, palpable lymphadenopathy, or abdominal masses. Auscultation of the chest was clear, and cardiac sounds were normal.

Imaging & Diagnostics

Initial Radiographs

Antero-posterior and lateral radiographs of the left femur revealed a highly destructive, lytic lesion in the distal diaphysis, extending into the metaphysis, measuring approximately 8 cm in length. The lesion demonstrated significant cortical breach and associated comminuted pathological fracture. The fracture pattern was spiral-oblique, with displacement and angulation. There was evidence of prior endosteal scalloping and thinning of the cortex, indicative of a pre-existing lesion. No periosteal reaction or new bone formation was observed, consistent with a rapidly destructive process. The contralateral femur and ipsilateral hip/knee joints appeared radiographically normal.

Computed Tomography (CT)

A CT scan of the left femur was performed with intravenous contrast to delineate the extent of bone destruction, cortical involvement, medullary canal compromise, and soft tissue mass.
* Bone Detail: The CT confirmed extensive destruction of the distal femoral diaphysis and metaphysis, with significant cortical erosion and a large, associated pathological fracture. The lytic nature of the lesion was prominent, with minimal sclerotic margin. There was complete involvement of the medullary canal.
* Soft Tissue Extent: A substantial extra-osseous soft tissue component was identified, measuring approximately 6 x 5 x 7 cm, with heterogeneous enhancement, indicative of a hypervascular tumor. This soft tissue mass extended into the quadriceps musculature and abutted the neurovascular bundle, though no direct invasion or compression of major vessels/nerves was noted on this initial scan.
* Surgical Planning: CT imaging was crucial for surgical templating, allowing for precise measurement of the lesion's extent, estimation of bone loss, and planning for appropriate implant size and type. It also allowed assessment of the remaining proximal bone stock for fixation, confirming adequate bone for intramedullary nail placement or distal femoral replacement.

Magnetic Resonance Imaging (MRI)

MRI of the left femur was obtained to further characterize the soft tissue component, intramedullary extent, and relationship to neurovascular structures.
* T1-weighted images: Showed a low signal intensity lesion replacing the normal fatty marrow, extending proximally into the mid-diaphysis and distally towards the knee joint. The extra-osseous component was also hypointense.
* T2-weighted/STIR images: Demonstrated high signal intensity within the lesion and the surrounding soft tissue mass, indicative of edema and high fluid content, typical of a hypervascular tumor. The perilesional edema extended several centimeters beyond the cortical breach.
* Post-contrast T1-weighted images (with fat saturation): Showed intense, heterogeneous enhancement of both the intraosseous and extra-osseous components, confirming the highly vascular nature of the lesion, characteristic of RCC metastasis. The proximal intramedullary spread was well-defined, aiding in determining safe resection margins. No direct neural invasion was confirmed, but the tumor was in close proximity to the femoral nerve and vessels.

Whole-Body Staging & Diagnostic Workup

• Technetium-99m Bone Scintigraphy: A whole-body bone scan was performed to rule out other skeletal metastases. It showed increased uptake in the left distal femur corresponding to the known lesion but no other significant foci of abnormal tracer accumulation, indicating this was likely an isolated skeletal metastasis or at least the only symptomatic one. Note: RCC metastases can sometimes be "cold" on bone scans due to their purely lytic nature, emphasizing the need for other imaging.
• CT Chest/Abdomen/Pelvis: Performed for re-staging. Revealed no evidence of pulmonary metastases, liver metastases, or local recurrence at the nephrectomy site. Adrenal glands were clear.
• Image-Guided Biopsy: A CT-guided core needle biopsy of the femoral lesion was performed to confirm the diagnosis prior to definitive surgical intervention. Histopathology revealed clear cell carcinoma, positive for PAX8 and CD10 immunohistochemical stains, consistent with metastatic Renal Cell Carcinoma.
• Laboratory Investigations:
  • Full Blood Count: Mild anemia (Hb 11.2 g/dL), otherwise unremarkable.
  • Renal Function: Creatinine 1.0 mg/dL, eGFR >60 mL/min/1.73m^2.
  • Liver Function Tests: Within normal limits.
  • Calcium & Albumin: Corrected calcium 10.8 mg/dL (mild hypercalcemia), albumin 3.9 g/dL. Parathyroid hormone-related protein (PTHrP) was elevated, suggesting humoral hypercalcemia of malignancy.
  • Electrolytes: Otherwise unremarkable.
  • ESR/CRP: Elevated (ESR 45 mm/hr, CRP 15 mg/L), non-specific inflammatory markers.
  • Coagulation Profile: INR, PTT within normal limits.

Pre-operative Embolization

Given the highly vascular nature of RCC metastases and the MRI findings of intense enhancement, a pre-operative angiography and selective trans-arterial embolization of the feeding vessels to the tumor was performed 48 hours prior to surgery by interventional radiology. This was crucial to minimize intraoperative blood loss. The procedure successfully identified and embolized multiple small arterial feeders from the profunda femoris and superficial femoral arteries.

Differential Diagnosis

The presentation of a pathological fracture in an elderly patient with a history of malignancy immediately raises suspicion for skeletal metastasis. However, other lytic lesions of bone must be considered.

Surgical Decision Making & Classification

The decision for surgical intervention in patients with skeletal metastases is complex, balancing oncological principles, pain control, functional outcomes, and patient's overall prognosis. For this patient, the acute pathological fracture necessitated operative intervention.

Why Operative?

• Acute Pathological Fracture: A displaced, comminuted pathological fracture of a major load-bearing bone (femur) mandates stabilization to relieve excruciating pain, restore mechanical stability, and allow for early mobilization and weight-bearing. Non-operative management would condemn the patient to prolonged bed rest, with associated risks of pneumonia, DVT, skin breakdown, and severe pain.
• Impending Fracture Risk (Mirels' Score): Even prior to the fall, the patient's increasing pain and radiographic evidence of extensive cortical destruction in the distal femur (a critical load-bearing region) indicated a high risk of impending pathological fracture. While the fracture is now present, the concept of Mirels' score remains relevant for assessing other at-risk lesions.
  • Mirels' Scoring System for Impending Pathological Fracture:
    • Location: Lower extremity (femur) = 3 points
    • Pain: Functional (severe, rest pain) = 3 points
    • Lesion Type: Lytic = 2 points
    • Size: >2/3 cortical destruction = 3 points
    • Total Score: 3+3+2+3 = 11 points . A score >7-8 typically warrants prophylactic stabilization. This patient, with a score of 11, was at extremely high risk, and the fracture was unfortunately inevitable.
• Pain Relief: Surgical stabilization provides immediate and dramatic pain relief by stabilizing the fracture fragments.
• Functional Restoration: Allows for early ambulation, improving quality of life and preventing complications of immobility.
• Local Tumor Control: While not a curative procedure, surgical debridement and reconstruction can reduce tumor burden locally.
• Histological Diagnosis: Confirmed by biopsy, but surgery provides larger specimens if needed for further molecular testing.
• Hypervascularity Management: Pre-operative embolization and intraoperative control of bleeding are crucial for RCC metastases, which are notoriously vascular.

Why Not Non-Operative?

• Non-operative management of a displaced femoral pathological fracture is generally reserved for patients with extremely limited life expectancy (<1-2 months), uncontrolled systemic disease, or prohibitive surgical risks. In this case, with a history of RCC but no other systemic metastases detected on re-staging and a relatively good performance status (ECOG 2 due to pain, but otherwise healthy), non-operative management was not indicated.

Classification Systems Guiding Decision Making:

• Harrington Classification for Spinal Metastases: While not directly applicable to a femoral lesion, its principles regarding spinal stability, neurological involvement, and life expectancy are instructive. Harrington categorized lesions by neurological status and bone involvement, guiding surgical approach (decompression, stabilization, reconstruction).
• Tokuhashi Score: Predicts survival in spinal metastasis patients (0-15 points, correlating with survival <6 months to >1 year). Elements like KPS, number of extraskeletal metastases, paralysis, and organ metastases influence the score. For a non-spinal metastasis, an analogous assessment of overall prognosis and systemic disease burden is crucial, even if a formal Tokuhashi score isn't calculated. This patient's overall good health, controlled primary disease, and absence of other metastases suggested a longer prognosis (likely >6 months, potentially >1 year), supporting aggressive surgical management.
• Enneking Staging System: Primarily for primary bone sarcomas, this system categorizes tumors based on grade, local extent (intra/extra-compartmental), and presence of metastasis. While not a sarcoma, the principles of assessing local tumor burden and systemic spread are fundamental to managing metastatic disease. This patient had a "Stage III" equivalent disease from an orthopedic perspective (localized skeletal metastasis in a patient with a known history of systemic cancer).
• Weinstein-Boriani-Biagini (WBB) Classification: Used for spinal tumors, it provides a detailed anatomical classification (zones, layers) to guide surgical resection margins. While not directly for femur, it highlights the importance of detailed anatomical assessment for tumor resection and reconstruction planning.

Based on the clinical presentation, imaging, and patient's overall health, the decision was made for immediate surgical stabilization and reconstruction of the pathological fracture, following pre-operative embolization. The choice of implant would depend on the extent of bone loss and location. Given the distal femoral metadiaphyseal location, options included a long intramedullary nail with cement augmentation or a distal femoral endoprosthetic replacement. Considering the extensive cortical destruction and potential for widespread intramedullary disease, a distal femoral endoprosthetic replacement was chosen for durable reconstruction and immediate weight-bearing.

Surgical Technique / Intervention

Pre-operative Considerations

• Multidisciplinary Tumor Board Discussion: Case presented to a tumor board including orthopedic oncology, medical oncology, radiation oncology, interventional radiology, and pathology to optimize treatment strategy. Consensus was for surgical stabilization given acute fracture, followed by adjuvant systemic therapy and potentially radiotherapy.
• Pre-operative Embolization: As described, performed 48 hours prior to surgery to reduce intraoperative blood loss. This is critical for RCC metastases.
• Patient Optimization: Assessment of cardiorespiratory status, correction of mild hypercalcemia (with IV fluids, bisphosphonates), optimization of nutritional status, and standard pre-operative antibiotic prophylaxis (e.g., Cefazolin). Availability of adequate blood products (cross-matched units) was ensured.

Patient Positioning & Approach

• The patient was positioned supine on a radiolucent operating table, allowing for fluoroscopic imaging. A tourniquet was applied high on the thigh but not inflated until definitive vascular control was achieved.
• The limb was prepped and draped from the iliac crest to the foot.
• A standard lateral extensile approach to the distal femur was utilized. A longitudinal skin incision was made extending from the lateral aspect of the distal thigh proximally for approximately 25 cm, centered over the fracture site. The iliotibial band was incised longitudinally. The vastus lateralis muscle was elevated anteriorly from the lateral intermuscular septum to expose the distal femur. Care was taken to protect the sciatic nerve posteriorly and the femoral neurovascular bundle anteriorly.

Surgical Technique / Fixation Construct

1. Exposure and Debridement: The pathological fracture site was exposed. A significant amount of hemorrhagic, friable tumor tissue was encountered, confirming the highly vascular nature of the lesion, despite embolization. Gross tumor was meticulously debulked and debrided from the fracture site and surrounding soft tissues. Intralesional curettage was performed to remove as much intramedullary tumor as safely possible without compromising soft tissue envelopes. Multiple biopsies were sent for frozen section and permanent histopathology to confirm tumor type and assess margins where possible.
2. Assessment of Bone Loss and Reconstruction Decision: After debridement, the extent of bone loss and cortical destruction was reassessed. Given the comminution, significant bone void, and the goal of durable fixation and immediate weight-bearing, a distal femoral endoprosthesis was confirmed as the ideal reconstructive option. The remaining proximal femoral diaphysis and distal articular surface of the knee were carefully evaluated for suitable resection levels.
3. Resection: The distal femur was resected en bloc, approximately 12 cm from the articular surface, aiming for a clean margin in the bone and removal of the entire tumor-involved segment. An oscillating saw was used for precise bone cuts. The knee joint capsule and ligaments were preserved where possible, but a standard knee arthrotomy was performed for prosthesis placement.
4. Prosthesis Implantation: A modular distal femoral endoprosthesis (e.g., Stryker GMRS or Zimmer Trabecular Metal) was selected based on pre-operative templating.
   • The intramedullary canal of the remaining proximal femur was reamed to the appropriate size.
   • The femoral stem of the endoprosthesis was inserted and cemented into the reamed canal using high-viscosity bone cement.
   • The articular component of the prosthesis (condylar replacement) was then assembled onto the stem.
   • The soft tissues were meticulously repaired around the prosthesis to provide stability and minimize dead space. The patellar tendon, collateral ligaments, and capsule were reattached as functionally as possible to the prosthesis.
5. Cement Augmentation (if IMN): Had an intramedullary nail been chosen for a more diaphyseal lesion, the technique would involve:
   • Reaming: Reaming the medullary canal to the appropriate size for the nail.
   • Tumor Curettage: Extensive intralesional curettage to remove tumor from the canal.
   • Nail Insertion: Insertion of a long, locked intramedullary nail (e.g., IMN for distal femur) extending well beyond the lesion proximally and distally, ensuring at least 2 cortical diameters of healthy bone engagement.
   • Cement Augmentation: After nail insertion, the tumor cavity would be augmented with polymethylmethacrylate (PMMA) bone cement. This serves multiple purposes: provides structural support, enhances screw purchase, fills dead space, and the exothermic reaction can provide some local tumor ablation. Careful irrigation and suction during cement polymerization are crucial to manage heat.
   • Locking: Distal and proximal locking screws were inserted to provide rotational and axial stability.
6. Wound Closure: After thorough irrigation, drains were placed. The vastus lateralis was repaired to the lateral intermuscular septum. The iliotibial band and subcutaneous tissues were closed in layers. Skin was closed with staples.

Intraoperative Considerations

• Blood Loss: Significant blood loss is anticipated, even with embolization. Meticulous hemostasis, careful use of electrocautery, and suction/irrigation were continuously employed. Cell Saver was utilized.
• Neurovascular Protection: The femoral neurovascular bundle (anteriorly) and sciatic nerve (posteriorly) were identified and protected throughout the dissection and bone cuts.
• Bone Cement Handling: Proper mixing, timing, and insertion technique for PMMA cement are crucial to maximize strength and minimize thermal injury if used.
• Prophylactic Radiation (for remaining bone/soft tissue): Not performed intraoperatively but considered in the post-operative plan.

Post-Operative Protocol & Rehabilitation

Immediate Post-Operative Period (Days 0-7)

• Pain Management: Multimodal analgesia including IV opioids (patient-controlled analgesia), regional nerve blocks (adductor canal block), NSAIDs (if not contraindicated), and acetaminophen. Weaning to oral medications as tolerated.
• Wound Care: Daily dressing changes, monitoring for infection, hematoma, or wound dehiscence. Drains typically removed when output is minimal (<30-50 mL/24h).
• DVT Prophylaxis: Pharmacological (e.g., enoxaparin 40 mg SC daily) and mechanical (intermittent pneumatic compression devices) initiated immediately and continued for at least 4-6 weeks post-operatively.
• Mobilization:
  • Day 0-1: Bed mobility, deep breathing exercises, ankle pumps. Early physical therapy assessment.
  • Day 2-3: Initiation of out-of-bed transfers with assistance.
  • Weight-Bearing: Immediate full weight-bearing as tolerated on the operative limb due to the stability of the endoprosthesis. This is a significant advantage over other fixation methods or primary bone healing.
• Laboratory Monitoring: CBC (for anemia), electrolytes (hypercalcemia management, if still present), renal function.
• Adjuvant Therapy Discussion: Close coordination with medical oncology and radiation oncology teams for planning systemic therapy (targeted agents such as tyrosine kinase inhibitors or immunotherapy) and/or post-operative radiation therapy to local soft tissue margins to reduce recurrence risk, as RCC is often radioresistant but can respond to high-dose, focused radiation.

Early Rehabilitation (Weeks 1-6)

• Physical Therapy: Focus on regaining knee range of motion (active and passive), strengthening of quadriceps, hamstrings, and hip abductors. Gradual progression of ambulation with assistive devices (walker, then cane) as confidence and strength improve.
• Occupational Therapy: Assessment of activities of daily living (ADLs), adaptive equipment needs, home safety assessment.
• Pain Management: Transition to oral analgesics, stepping down from opioids as pain subsides. Neuropathic pain medications if indicated.
• Monitoring for Complications: Infection, DVT/PE, prosthesis loosening/failure, neurovascular injury, local recurrence.

Late Rehabilitation & Long-Term Follow-up (Months 2+)

• Physical Therapy: Advanced strengthening exercises, balance training, gait training to achieve independent ambulation. Return to light recreational activities.
• Oncologic Surveillance:
  • Clinical: Regular follow-up with orthopedic oncology, medical oncology, and primary care physician.
  • Imaging: Repeat CT chest/abdomen/pelvis every 3-6 months for the first 2 years, then annually, to monitor for new metastases. Plain radiographs of the operative limb annually to assess prosthesis integrity and bone-cement interface.
  • Laboratory: Regular blood tests including CBC, LFTs, renal function.
• Psychosocial Support: Addressing patient's anxiety, depression, and adjustment to life with a major prosthetic implant and ongoing cancer diagnosis.
• Nutritional Support: Ensuring adequate nutrition for healing and overall well-being.

The goal of post-operative management for this patient is to optimize functional recovery, manage pain, minimize complications, and integrate orthopedic care with comprehensive oncological treatment, thus maximizing quality of life within the context of his metastatic disease.

Pearls & Pitfalls (Crucial for FRCS/Board Exams)

Pearls

• High Index of Suspicion: Always suspect pathological fracture in a patient with a known history of malignancy presenting with sudden, severe pain following a trivial mechanism of injury or with worsening focal bone pain. "Old age" aches should always be investigated.
• Mirels' Score is Key: Utilize Mirels' score (Location + Pain + Lesion Type + Size) for every patient with a bone lesion and known malignancy. A score ≥ 7-8 is a strong indication for prophylactic stabilization to prevent impending fracture.
• RCC is Hypervascular: Renal Cell Carcinoma metastases are notoriously hypervascular. Pre-operative angiography and embolization are paramount to minimize catastrophic intraoperative hemorrhage. Failure to embolize can lead to massive blood loss and compromise patient safety.
• Multidisciplinary Approach: Management of skeletal metastases is never solely orthopedic. Engage medical oncology, radiation oncology, interventional radiology, and palliative care early and routinely via a tumor board to create a comprehensive, individualized treatment plan.
• Cement Augmentation: Polymethymethacrylate (PMMA) cement is your friend. When using intramedullary nails or plates for metastatic lesions, cement augmentation of the tumor cavity significantly enhances construct stability, provides pain relief, and can offer some local tumor control (thermal effect).
• Function over Cure: For most metastatic lesions, the primary goals are pain relief, functional restoration, and improving quality of life, rather than outright cure. The surgical strategy should align with the patient's expected life expectancy and overall disease burden.
• Prognostic Scoring: Understand and apply prognostic scores like Tokuhashi or Katagiri to guide the aggressiveness of surgical intervention, especially in spinal metastases, but the principles extend to other sites.
• Reconstructive Ladder: Be prepared for various reconstructive options: IMN for diaphyseal lesions, plates for metaphyseal, and endoprosthetic reconstruction for extensive bone loss or periarticular destruction. The latter offers immediate stability and weight-bearing.
• Hypercalcemia Management: Be aware of humoral hypercalcemia of malignancy, which is common in RCC. Correct pre-operatively with hydration and bisphosphonates.
• Adjuvant Therapy Integration: Understand how radiation and systemic therapies (TKIs, immunotherapy for RCC) integrate with surgical management.

Pitfalls

• Inadequate Staging: Proceeding with surgery without full restaging (CT C/A/P, bone scan, +/- PET-CT) to identify other active sites of disease or primary disease progression. This can lead to inappropriate treatment.
• Underestimating Vascularity: Failure to recognize the hypervascular nature of RCC metastases and skipping pre-operative embolization is a critical error leading to dangerous intraoperative blood loss and increased morbidity/mortality.
• Suboptimal Fixation: Using an implant that is too short, too weak, or not augmented with cement for the extensive bone destruction typical of metastasis. This leads to early hardware failure, re-fracture, and repeat surgery.
• Ignoring Systemic Disease: Focusing solely on the orthopedic problem without considering the overall oncological picture and systemic treatment plan. This leads to fragmented care and poorer outcomes.
• Delay in Diagnosis: Attributing pain to benign causes (e.g., "arthritis," "muscle strain") in a cancer patient, delaying investigation and treatment of a pathological lesion.
• Nerve/Vessel Injury: Inadequate exposure and protection of neurovascular structures during aggressive tumor debridement, especially with large soft tissue masses.
• Poor Patient Selection: Operating on patients with extremely poor performance status or very short life expectancy where the morbidity of surgery outweighs the potential benefits.
• Not Obtaining Biopsy: In cases where the primary is unknown or there is doubt, always obtain a biopsy to confirm diagnosis before definitive surgery, as different tumors have different sensitivities to adjuvant therapies.
• Inadequate Pain Management: Underestimating the severity and complexity of cancer-related pain. Comprehensive, multimodal pain management is crucial throughout the patient's journey.